Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Reduction in short-acting insulin requirement accompanies improved glycemic control with basal insulin peglispro compared with insulin glargine in patients with type 1 diabetes.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- معلومة اضافية
- المصدر:
Publisher: Blackwell Publishing Asia Country of Publication: Australia NLM ID: 101504326 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1753-0407 (Electronic) Linking ISSN: 17530407 NLM ISO Abbreviation: J Diabetes Subsets: MEDLINE
- بيانات النشر:
Original Publication: Richmond, Vic. : Blackwell Publishing Asia, 2009-
- الموضوع:
- Contributed Indexing:
Keywords: hypoglycemia; insulin glargine; insulin peglispro; short-acting insulin; type 1 diabetes mellitus
- Molecular Sequence:
ClinicalTrials.gov NCT01049412
- الرقم المعرف:
0 (Hypoglycemic Agents)
0 (Insulin Lispro)
2ZM8CX04RZ (Insulin Glargine)
- الموضوع:
Date Created: 20150818 Date Completed: 20161018 Latest Revision: 20161230
- الموضوع:
20231215
- الرقم المعرف:
10.1111/1753-0407.12332
- الرقم المعرف:
26278063
No Comments.